12/21/2006

The FDA approved Johnson & Johnson's schizophrenia drug Invega, or paliperidone, which is derived from the drug risperidone, sold under the brand name Risperdal. Invega will be sold in extended-release tablet form. The price was not released.

Full Story:
USA Today

Related Summaries